CoChat

Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure

Open access
Lontchi-Yimagou, Eric, Aleksic, Sandra, Hulkower, Raphael, Gospin, Rebekah, Goyal, Akankasha, Kuo, Bryan, Mitchell, William G, You, Jee Young, Upadhyay, Laxmi, Carey, Michelle, Sandu, Oana A, Gabriely, Ilan, Shamoon, Harry, Hawkins, Meredith · 2020 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; 16 of the 43 sources its claims cite were checked for support.

Abstract

Background: Recurrent hypoglycemia blunts counter-regulatory responses to subsequent hypoglycemic episodes, a syndrome known as hypoglycemia-associated autonomic failure (HAAF). Since adrenergic receptor blockade has been reported to prevent HAAF, we investigated whether the hypoglycemia-associated rise in plasma epinephrine contributes to pathophysiology and reported interindividual differences in susceptibility to HAAF. Methods: To assess the role of hypoglycemia-associated epinephrine responses in the susceptibility to HAAF, 24 adult nondiabetic subjects underwent two 2-hour hyperinsulinemic hypoglycemic clamp studies (nadir 54 mg/dL; 0-2 hours and 4-6 hours) on Day 1, followed by a third identical clamp on Day 2. We challenged an additional 7 subjects with two 2-hour infusions of epinephrine (0.03 μg/kg/min; 0-2 hours and 4-6 hours) vs saline on Day 1 followed by a 200-minute stepped hypoglycemic clamp (90, 80, 70, and 60 mg/dL) on Day 2. Results: Thirteen out of 24 subjects developed HAAF, defined by ≥20% reduction in average epinephrine levels during the final 30 minutes of the third compared with the first hypoglycemic episode (P < 0.001). Average epinephrine levels during the final 30 minutes of the first hypoglycemic episode were 2.3 times higher in subjects who developed HAAF compared with those who did not (P = 0.006). Compared to saline, epinephrine infusion on Day 1 reduced the epinephrine responses by 27% at the 70 and 60 mg/dL glucose steps combined (P = 0.04), with a parallel reduction in hypoglycemic symptoms (P = 0.03) on Day 2. Conclusions: Increases in plasma epinephrine reproduce key features of HAAF in nondiabetic subjects. Marked interindividual variability in epinephrine responses to hypoglycemia may explain an individual’s susceptibility to developing HAAF.

Overview

CoChat Summary

TL;DR

In nondiabetic adults, higher plasma epinephrine responses during initial hypoglycemia predicted susceptibility to experimental hypoglycemia-associated autonomic failure (HAAF), and repeated epinephrine infusions without hypoglycemia reproduced key HAAF features during later hypoglycemia. These findings support plasma epinephrine as a contributor to HAAF pathogenesis.

Key findings

  • In Protocol 1, 13 of 24 subjects (54%) developed HAAF, defined as ≥20% reduction in average epinephrine during the final 30 minutes of the third vs first hypoglycemic episode; their epinephrine fell from 906 ± 145 to 550 ± 113 pg/mL (P < 0.001).
  • Subjects who developed HAAF had ~2.3 times higher average epinephrine during the final 30 minutes of the first hypoglycemic episode than those who did not (906 ± 145 vs 398 ± 77 pg/mL; P = 0.006); non-HAAF subjects instead increased epinephrine from 398 ± 77 to 542 ± 93 pg/mL (P = 0.04).
  • In Protocol 2, antecedent epinephrine infusion vs saline reduced subsequent epinephrine responses by 27% at the 70 and 60 mg/dL glucose steps combined (237 [134, 347] vs 325 [237, 526] pg/mL; P = 0.04), with a parallel reduction in hypoglycemic symptoms (P = 0.03).
  • Hypoglycemia symptom scores were significantly lower at glucose steps 70 mg/dL, 60 mg/dL, and 70 and 60 mg/dL combined (P = 0.049, P = 0.048, and P = 0.03, respectively) after epinephrine vs saline infusion.

Methods

  • Protocol 1: 24 healthy nondiabetic subjects (age 43 ± 2 years, 21 male, BMI 25.1 ± 0.5 kg/m²) underwent three identical 2-hour hyperinsulinemic hypoglycemic clamps targeting 54 mg/dL: two on Day 1 (0–2 and 4–6 hours) and one on Day 2.
  • Protocol 2: 7 healthy male nondiabetic subjects (age 32 ± 4 years, BMI 25.0 ± 0.5 kg/m², HbA1c 5.5 ± 0.1%) were studied in a randomized, crossover, single-blind design with two 2-hour epinephrine infusions (0.03 µg/kg/min) or normal saline on Day 1, followed by a 200-minute stepped hyperinsulinemic hypoglycemic clamp (90, 80, 70, and 60 mg/dL, each 50 minutes) on Day 2.
  • Analyses used paired t tests, independent samples t tests, and Wilcoxon matched-pairs signed-rank tests, with P < 0.05 considered significant; statistical analyses were performed using Stata version 15.1.

Limitations

  • The authors state that different hypoglycemic clamp techniques were used in the two protocols (single 54 mg/dL target vs stepped 90–60 mg/dL), which could affect the magnitude of findings, though they argue the overall direction should not be affected.
  • The authors state that EGP did not differ following epinephrine vs saline, perhaps due to tracer equilibration issues because exogenous glucose was infused throughout; they also note limited data points during the second hypoglycemia episode.
  • Evident from the text: Protocol 2 was small (n = 7), male-only, nondiabetic, and single-blind, limiting generalizability; the authors state it remains important to establish whether these observations extend to individuals with type 1 diabetes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/clinem/dgaa539

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

13 Valid · 0 Not valid · 19 Not checked · 44 Own results and interpretations

40 more claims · 1 with their cited sources checked

Create a free account to see all 76 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 13

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 59 references

Cited by

See all 17

Metadata

Authors
Lontchi-Yimagou, E., Aleksic, S., Hulkower, R., Gospin, R., Goyal, A., Kuo, B., Mitchell, W. G., You, J. Y., Upadhyay, L., Carey, M., Sandu, O. A., Gabriely, I., Shamoon, H., & Hawkins, M.
Affiliations
  • Albert Einstein College of Medicine, Bronx, New York
  • Albert Einstein College of Medicine (US)
  • NYU Langone Health (US)
  • United States Food and Drug Administration (US)
Corresponding author
Hawkins, Meredith
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2020-09-09
Volume
105
Issue
11
Pages
3416-3427
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W3083871319
Cited by
17
References
58
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 1 · 2020: 1
FWCI
1.51
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK069861, DK079974)
  • Einstein-Mount Sinai Diabetes Research Center (5P30DK020541-41)
  • National Center for Advancing Translational Sciences
  • Einstein-Montefiore Clinical and Translational Science Awards (UL1TR001073, UL1TR002556)
  • American Diabetes Association (1-18-PMF-024)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
hypoglycemia-associated autonomic failure, plasma epinephrine, recurrent hypoglycemia, counterregulatory response, adrenergic blockade, epinephrine infusion, interindividual variability, hypoglycemic symptoms, hyperinsulinemic hypoglycemic clamp, non-diabetic patients
MeSH terms
Adult, Autonomic Nervous System, Autonomic Nervous System Diseases, Blood Glucose, Epinephrine, Female, Humans, Hypoglycemia, Insulin, Male, Middle Aged, Glucose Clamp Technique

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure. https://app.cochat.ai/papers/10.1210/clinem/dgaa539
The paper
Lontchi-Yimagou, E., Aleksic, S., Hulkower, R., Gospin, R., Goyal, A., Kuo, B., Mitchell, W. G., You, J. Y., Upadhyay, L., Carey, M., Sandu, O. A., Gabriely, I., Shamoon, H., & Hawkins, M. (2020). Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaa539

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.